UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
______________________________________________
FORM 8-K
______________________________________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) March 31, 2011
______________________________________________
BIOSCRIP, INC.
(Exact name of Registrant as specified in its charter)
______________________________________________
Delaware 0-28740 05-0489664
(State of Incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)
100 Clearbrook Road, Elmsford, New York 10523
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (914) 460-1600
N/A
(Former name or former address, if changed since last report)
______________________________________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
(b) Departure of Principal Accounting Officer
On March 31, 2011, the employment of Mr. Phillip Keller, Vice President of Finance and Principal Accounting Officer of BioScrip, Inc. (the "Company") was terminated.
(c) Appointment of Principal Accounting Officer
In addition, effective April 1, 2011, Ms. Patricia Bogusz, the Company’s Vice President - Controller was appointed Vice President of Finance and has been named Principal Accounting Officer to replace Mr. Keller. Ms. Boguz joined the Company in October of 2005 as Director of Internal Audit. In June of 2007, Ms. Boguz was promoted to Vice President - Controller.
2
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
BIOSCRIP, INC.
Date: April 4, 2011 /s/ Barry A. Posner
By: Barry A. Posner
Executive Vice President, Secretary and General Counsel
3